Elías Campo joins the Royal Academy of Medicine of Catalonia

Elías Campo during his speech at the Royal Academy of Medicine of Catalonia. Photo: RAMC
Elías Campo during his speech at the Royal Academy of Medicine of Catalonia. Photo: RAMC
Institutional
(16/10/2017)

Professor Elías Campo, from the Department of Basic Clinical Practice and research and innovation director of Hospital Clínic, director of August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and Clinic Foundation for Biomedical Research, has joined the Royal Academy of Medicine of Catalonia (RAMC) as Numerary Academician. The welcoming ceremony took place on October 8, in a public extraordinary session at the headquarters of the Royal Academy of Medicine, where Campo read the speech “Lʼanatomia Patològica, una visió integradora de la malaltia des del microscopi fins al genoma”. The speech was answered by the numerary academician Antoni Cardesa.

Elías Campo during his speech at the Royal Academy of Medicine of Catalonia. Photo: RAMC
Elías Campo during his speech at the Royal Academy of Medicine of Catalonia. Photo: RAMC
Institutional
16/10/2017

Professor Elías Campo, from the Department of Basic Clinical Practice and research and innovation director of Hospital Clínic, director of August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and Clinic Foundation for Biomedical Research, has joined the Royal Academy of Medicine of Catalonia (RAMC) as Numerary Academician. The welcoming ceremony took place on October 8, in a public extraordinary session at the headquarters of the Royal Academy of Medicine, where Campo read the speech “Lʼanatomia Patològica, una visió integradora de la malaltia des del microscopi fins al genoma”. The speech was answered by the numerary academician Antoni Cardesa.

Elías Campo has co-led together with Carlos Lopez-Otín, researcher of the University of Oviedo, the studies on the whole genome sequencing on T cell chronic lymphocytic leukaemia and the epigenome of this disease (changes in the genetic material and its regulatory proteins). Chronic lymphocytic leukaemia is most common in western countries, with more than a new thousand patients diagnosed in Spain per year. These studies, with normal and cancer cell genome sequencing in more than five-hundred patients was a milestone in cancer genomic research.

Further information